Capsule dosage form of metoprolol succinate

US9700530B2 · kind B2 · utility

Assignee

• SUN PHARMACEUTICAL INDUSTRIES LIMITED · IN

Inventors

• Sandeep Kumar VATS · Sonipat, IN
• Balaram MONDAL · Kamjong, IN
• Kalaiselvan RAMARAJU · Tiruchirappalli, IN
• Romi Barat Singh · Varanasi, IN

Key dates

• Filing date: Oct 28, 2016
• Grant date: Jul 11, 2017
• Expiry date: Oct 28, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/5047
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This disclosure provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units, wherein said capsule dosage form is bioequivalent to the marketed Toprol-XL® tablet. The extended-release capsule dosage form comprising coated discrete units can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules.